Stockreport

GeoVax Expands Gedeptin(R) Development to Additional Solid Tumor Indications [Yahoo! Finance]

GeoVax Labs, Inc.  (GOVX) 
NASDAQ:AMEX Investor Relations: geovax.com/contact-geovax.html
PDF ATLANTA, GA - September 24, 2025 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies aga [Read more]